Cargando…
SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035603/ https://www.ncbi.nlm.nih.gov/pubmed/33839737 http://dx.doi.org/10.1038/s41392-021-00592-6 |
_version_ | 1783676734420287488 |
---|---|
author | Li, Maochen Lou, Fuxing Fan, Huahao |
author_facet | Li, Maochen Lou, Fuxing Fan, Huahao |
author_sort | Li, Maochen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8035603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80356032021-04-12 SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency Li, Maochen Lou, Fuxing Fan, Huahao Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2021-04-10 /pmc/articles/PMC8035603/ /pubmed/33839737 http://dx.doi.org/10.1038/s41392-021-00592-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Highlight Li, Maochen Lou, Fuxing Fan, Huahao SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency |
title | SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency |
title_full | SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency |
title_fullStr | SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency |
title_full_unstemmed | SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency |
title_short | SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency |
title_sort | sars-cov-2 variants: a new challenge to convalescent serum and mrna vaccine neutralization efficiency |
topic | Research Highlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035603/ https://www.ncbi.nlm.nih.gov/pubmed/33839737 http://dx.doi.org/10.1038/s41392-021-00592-6 |
work_keys_str_mv | AT limaochen sarscov2variantsanewchallengetoconvalescentserumandmrnavaccineneutralizationefficiency AT loufuxing sarscov2variantsanewchallengetoconvalescentserumandmrnavaccineneutralizationefficiency AT fanhuahao sarscov2variantsanewchallengetoconvalescentserumandmrnavaccineneutralizationefficiency |